E D U C AT I O N

1986 M.D. Columbia – College of Physicians and Surgeons

1982 PreMed Harvard University and Brandeis University

1979 B.A. Brandeis University

P O S T D O C T O R A L T R A I N I N G

1994 Post Graduate in Biochemotherapy of Renal Cell Carcinoma and Melanoma MD Anderson Cancer Center, Houston, Texas

1989-1991 Fellow, Neoplastic Diseases Mt. Sinai Medical Center, New York, New York

1986-1989 Resident, Internal Medicine St. Lukes – Roosevelt Hospital, New York, New York

C U R R E N T P R A C T I C E

2012 - Present Personalized Cancer Medicine, PLLC Honolulu, Hawaii

C E R T I F I C AT I O N

American Board of Internal Medicine

American Board of Medical Oncology

NIH Certification of Human Subjects Research

A C A D E M I C A P P O I N T M E N T S

2001 - Present Clinical Associate Professor of Medicine University of Vermont, Burlington, Vermont

Michael Castro, MD Senior Medical Director

© 2013 Caris Life Sciences and affiliates. All rights reserved. TN0103 1.13

Pharmacokinteics Of Bsi-201, A Poly (Adp-Ribose) Polymerase-1 (Parp1) Inhibitor In Cerebrospinal Fluid Of A Breast Cancer Patient With Carcinomatous Meningitis. M Castro, L Li, Te Stallings. Proc Am Soc Clin Oncol 2010, Abstract 48374

Peripheral Sensory Neuropathy - Fighting Cold With Cold. Castro Mp Lancet Oncol 2008 9:415-6

Pharmacogenetics In The Clinic: The New Questions About Tamoxifen. Castro Mp. J Oncol Prac 2006 2:100

Resisting A Fundamentalist Philosophy. M Castro J Clin Oncol 2005 23:3645-46

Bisphosphonate-Induced Osteosclerosis In A Breast Cancer Patient. Castro Mp, Novak S, Whyte Mp. J Bone & Mineral Res 2005

Pharmacogenetic Correlates Of Benefit From Gemcitabine And Platinum In Patients With Advanced Bladder Cancer. M Castro, A Neumann, M Konichexky, K Dannenberg, S Stemmer Proc Am Soc Clin Oncol 2004 Abstract 3203

Thymidine Rescue: An Antidote For Pemetrexed Related Toxicity In The Setting Of Acute Renal Failure, M. Castro, J Clin Oncol 2003, 21:4066

Targeted Therapy. M. Castro In Heme-Onc Secrets Ed. M. Wood. University Of Vermont Press 2003.

Timing Is Everything Or Could Be. M. Castro J Clin Oncol 21: 755, 2003.

The Simpleton’s Error In Drug Development. M. Castro. J Clin Oncol 2002 20: 4606-7.

Eniluracil’s Need For A Targeted Approach: A Lesson In Drug Development. M Castro. J Clin Oncol 2002 20: 3750.

Ex-Vivo Apoptotic Assay (Eva)-Directed Use Of Gemcitabine As Salvage Therapy In Colorectal Carcinoma: Case Report. M Castro. Lilly Oncology Investigators Meeting. April 4, 2002

Successful Use Of Anti-Cd20 Monoclonal Antibody, Rituxan, In Patients With Non-Hodgkin’s Lymphoma And Renal Insufficiency. Castro Mp, Vanauken J, Sponzo Rw. Proc. Am Soc Clin Oncol 2001, 20:3325.

Cerebrospinal Fluid Gastrin-Releasing Peptide In The Diagnosis Of Leptomeningeal Metastases In Small Cell Carcinoma. Mp Castro, S Qualman, T Odorisio, Cancer 2001, 91:2122-2126.

Cyclophosphamide, 5-Fluorouracil And Prednisone (Cfp) In Hormone Refractory Prostate Cancer. Mp Castro, J Vanauken, N Oberhelman, Rw Sponzo. Proc Am Soc Clin Oncol. 2000, 19:1435,.

The Impact Of Risk Stratification Of Mammographic Interpretation. R Sponzo, T Ashikaga, C Howland, P Cisek, Mp Castro. Proc Am Soc Clin Oncol 2000, 19:335.

Have The Recently Completed Phase Iii Trials Significantly Impacted Adjuvant Treatment Choices For Stage Ii Breast Carcinoma? Middleman E, Castro Mp, Gradishar W. Semin Oncol, 1999, 26(4): Xvi, Xvii-Xx,.

Acute Tumor Lysis Syndrome Associated With Concurrent Biochemotherapy Of Metastatic Melanoma: A Case Report And Review Of The Literature. Castro Mp, S Legha, J Van Auken, P Cisek, Rw Sponzo. Cancer 1999 85(5): 1055-9.

Efficacy Of Gemcitabine In The Treatment Of Patients With Gallbladder Carcinoma; A Case Report. M. Castro, Cancer 1998, 82(4): 639-41.

Clinicopathologic Correlations With Mucin Carbohydrate Antigen Expression In Breast Cancer. M. Castro, J. Strauchen, J. Mandeli, R. Perles, J. Morrison, S. Itzkowitz. Proc Am Soc Clin Oncol, 1991 10:200.

S E L E C T P U B L I C AT I O N S

P R O F E S S I O N A L S O C I E T I E S

American Society of Clinical Oncology American Medical Association

To order Caris Molecular Intelligence Services or to speak with a Caris Life Sciences’ representative, call

( 8 8 8 ) 9 7 9 - 8 6 6 9 or visit us online at www.CarisMolecularIntelligence.com.